Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate: Reforming the Drug Approval Process According to Market Principles

This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process. Lack of competition in the drug approval process has led to exceedingly high drug development costs. High drug development costs combined with artificially low drug prices, obtained through price control legislation and legislation that eases the entry of generic products into the market, has caused lower levels of pharmaceutical research and development, innovation, and economic growth.Privatization, Competition, Monopoly, Innovation, Drugs, Generics, Pharmaceuticals

Einstein's Generation: The Origins of the Relativity Revolution

No abstract

A Look Back at the Ehrenfest Classification. Translation and Commentary of Ehrenfest's 1933 paper introducing the notion of phase transitions of different order

A translation of Paul Ehrenfest's 1933 paper, entitled "Phase transitions in the usual and generalized sense, classified according to the singularities of the thermodynamic potential" is presented. Some historical commentary about the paper's context is also given.Comment: 13p

Albert Einstein's 1916 Review Article on General Relativity

The first comprehensive overview of the final version of the general theory of relativity was published by Einstein in 1916 after several expositions of preliminary versions and latest revisions of the theory in November 1915. A historical account of this review paper is given, of its prehistory, including a discussion of Einstein's collaboration with Marcel Grossmann, and of its immediate reception.Comment: 27 pages, 1 jpg imag